Definition
A malignant sarcomatous tumour of infancy/early childhood arising in the lung or rarely from the parietal pleura2,7. This tumour is the pulmonary equivalent of other paediatric tumours such as Wilm's tumour, neuroblastoma, hepatoblastoma and retinoblastoma17.
Pleuropulmonary blastoma |
arising in |
congenital cystic adenomatoid malformation2,4,5 |
Rhabdomyosarcoma |
mesenchymal cystic hamartoma |
|
Pulmonary sarcoma |
congenital bronchogenic cyst2 |
|
Embryonal sarcoma |
||
Pulmonary blastoma of childhood |
Epidemiology
About 100 cases are recorded by the pleuropulmonary blastoma registry. Pleuropulmonary blastoma occurs in children up to 12 years of age21, usually by the age of 4 years, with a median age of 2 years3,4,5,15. Type I tumours occur in the youngest children, type III in th oldest17. 25% of cases are associated with a familial cancer syndrome and children may also develop cystic nephroma6, ovarian teratoma8 or intestinal polyps10. Prophylactic resection of congenital lung cysts is recommended20, despite which pleuropulmonary blastoma may develop14.
Clinical features
In infancy, presentation is often with respiratory distress4,17. Children develop fever17, chest pain and cough18.
There are unilateral, rarely bilateral10,12, pulmonary cysts17. Intracystic masses or septal thickening militate against a diagnosis of congenital adenomatoid malformation. There may be a pneumothorax.
There are three subtypes:
I, purely cystic: the multilocular cysts have thin walls.
II, cystic and solid:
III, purely solid: the solid areas are gelatinous and white, sometimes haemorrhagic. They may be massive, occupying an entire lobe or lung.
Type I: the multiple cysts are lined by respiratory type epithelium underlain by malignant cells forming a cambium layer. The latter consists of small cells and may show rhabdomyoblastic differentiation. There may be small nodules of fetal cartilage or hyalinised stroma.
Type II: the septal stroma is overgrown by sheets of small primitive cells. These may show rhabdomyoblastic differentiation or be undifferentiated.
Type III and solid areas of type II: there are mixed blastematous and sarcomatous appearances2, consisting of nodules of malignant cartilage, anaplastic and pleomorphic cells, rhabdomyosarcomatous foci11,16 and blastema-like areas. There are variable foci of haemorrhage, necrosis and fibrosis. There may be an entrapped bland epithelial component11.
epithelial component lining cysts or entrapped within solid areas0 |
|||
positive in mesenchymal component0,23 |
|||
rhabdomyosarcomatous component, less often in the small cell cambium layer0 |
|||
rhabdomyosarcomatous component, less often in the small cell cambium layer0 |
|||
cartilaginous nodules0,23 |
|||
Myoglobin |
1/123 |
||
Cytogenetics
There are several reports of gains in chromosome 81,13,19, specifically within the mesenchymal elements21. p53 mutations are common9.
Pulmonary blastoma: there is a malignant epithelial element.
Cystic synovial sarcoma: positive for EMA, CD99 and cytokeratins
Radical surgery combined with chemoradiotherapy4.
Type I: 80-90% five year disease-free survival
Types II and III: less than 50% five year survival4,11
Pleural and mediastinal involvement are associated with a worse prognosis17. The tumour recurs locally4 and metastasis to the central nervous system16 and bone: pancreatic22 and ocular4 metastases occur. Children may develop a second pleuropulmonary blastoma.
0Tumours of the Lung, Pleura, Thymus and Heart. WHO Classification of Tumours. IARC Press 2004.
This page last revised 5.5.2005.
©SMUHT/PW Bishop